Ubicom Holdings, Inc. [3937.T]
TOKYO, May 14 (Pulse News Wire) – Ubicom Holdings,inc. (3937.T) reported mixed results for its fiscal year ending March 2026, showing a decline in overall revenue but strong performance in its medical division.
Revenue was ¥1.351 billion compared to the previous year, while operating profit decreased to ¥1.351 billion. However, ordinary profit reached ¥1.351 billion, marking a significant improvement despite the impact of M&A-related expenses. In the medical sector, the company achieved record-high sales and operating profits driven by subscription models and strategic acquisitions. Key initiatives included the complete subsidiary acquisition of ISM Co. and the decision to subsume Radiance Wear Co.
Additionally, the launch of new products such as MightyChecker® Cloud X contributed to revenue growth. On the technology consulting side, UbiCom focused on transitioning towards high-value, high-productivity models through AI-driven development. While overall revenue declined due to a strategic reduction in low-margin projects, the Philippine branch saw increased profitability thanks to direct client contracts and expansion in the healthcare/life sciences sectors. Looking ahead, UbiCom plans to continue its M&A strategy and invest in AI-driven solutions to enhance long-term competitiveness and profitability. The company also aims to maintain stable dividend payouts, targeting more than ¥25 per share for the next fiscal year.
🟡 Confidence: Standard AI-translated content.